Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹5,055 Cr
Revenue (TTM)
₹1,244 Cr
Net Profit (TTM)
₹128 Cr
ROE
17 %
ROCE
19.1 %
P/E Ratio
39.4
P/B Ratio
5.3
Industry P/E
40.54
EV/EBITDA
26.9
Div. Yield
0 %
Debt to Equity
0.3
Book Value
₹167.7
EPS
₹22.4
Face value
10
Shares outstanding
57,224,929
CFO
₹344.73 Cr
EBITDA
₹510.32 Cr
Net Profit
₹308.51 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Innova Captab
| -20.9 | -3.4 | 8.8 | 70.3 | -- | -- | -- |
|
BSE Healthcare
| -5.7 | 2.2 | 5.8 | 19.5 | 22.9 | 22.6 | 9.7 |
|
BSE Small Cap
| -6.6 | 6.8 | 11.2 | 6.8 | 24.8 | 37.4 | 16.4 |
|
Company
|
2024
|
|---|---|
|
Innova Captab
| 110.3 |
|
BSE Small Cap
| 29.0 |
|
BSE Healthcare
| 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Innova Captab
|
882.6 | 5,054.7 | 1,243.7 | 128.3 | 13.0 | 13.8 | 39.4 | 5.3 |
| 875.1 | 7,924.2 | 2,115.1 | 272.4 | 17.8 | 14.2 | 29.1 | 4.0 | |
| 568.1 | 8,977.0 | 4,178.2 | 0.8 | -- | 0.1 | -- | 3.1 | |
| 1,193.2 | 9,767.4 | 1,006.9 | 160.4 | 20.4 | 12.6 | 61.5 | 7.5 | |
| 517.9 | 12,550.4 | 4,460.0 | 479.1 | 16.4 | 14.4 | 26.2 | 3.5 | |
| 404.6 | 4,992.5 | 1,859.8 | 90.8 | 10.4 | 7.4 | 55 | 4.0 | |
| 922.2 | 2,276.9 | 356.3 | 100.9 | 25.0 | 13.3 | 22.6 | 2.9 | |
| 262.5 | 2,334.2 | 780.4 | 63.4 | 12.6 | 12 | 35.3 | 3.8 | |
| 165.8 | 5,385.4 | 71.8 | -342.5 | -467.5 | -- | -- | -24.8 | |
| 1,000.3 | 2,947.2 | 245.3 | -50.8 | -18.5 | -40.5 | -- | 20.7 |
5 min read•By Vishal Goyal
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing... organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India. Read more
Incorporated
2005
Chairman
Manoj Kumar Lohariwala
Managing Director
Vinay Kumar Lohariwala
Headquarters
Navi Mumbai, Maharashtra
Website
Looking for more details about Innova Captab Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Innova Captab Ltd stood at ₹ 1,580 Cr as on 31-Mar-25
The share price of Innova Captab Ltd is ₹882.55 (NSE) and ₹883.30 (BSE) as of 21-May-2025 IST. Innova Captab Ltd has given a return of 70.28% in the last 1 years.
Innova Captab Ltd has a market capitalisation of ₹ 5,055 Cr as on 21-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Innova Captab Ltd is 5.27 times as on 21-May-2025, a 37% premium to its peers’ median range of 3.84 times.
The P/E ratio of Innova Captab Ltd is 39.41 times as on 21-May-2025, a 3% discount to its peers’ median range of 40.54 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Innova Captab Ltd and enter the required number of quantities and click on buy to purchase the shares of Innova Captab Ltd.
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
The promoters of Innova Captab Ltd are MANOJ LOHARIWALA and VINAY KUMAR LOHARIWALA. They collectively own 50.88 per cent of the total equity. The chairman of the company is Manoj Kumar Lohariwala
There is no promoter pledging in Innova Captab Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
12,274
|
|
|
9,199
|
|
|
8,602
|
|
|
7,219
|
|
|
5,231
|
|
|
4,794
|
|
|
2,875
|
|
|
2,299
|
|
|
2,147
|
| Innova Captab Ltd | Ratios |
|---|---|
|
Return on equity(%)
|
13.83
|
|
Operating margin(%)
|
12.98
|
|
Net Margin(%)
|
10.21
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Innova Captab Ltd was ₹128 Cr.
₹-27.80
(
